The store will not work correctly when cookies are disabled.
3-amino-5-(2,6-dichlorophenyl)-2-methyl-2,7-dihydro-6H-pyrazolo[3,4-b]pyridin-6-one
ID: ALA5187276
Chembl Id: CHEMBL5187276
PubChem CID: 168280317
Max Phase: Preclinical
Molecular Formula: C13H10Cl2N4O
Molecular Weight: 309.16
Associated Items:
Names and Identifiers
Canonical SMILES: Cn1nc2[nH]c(=O)c(-c3c(Cl)cccc3Cl)cc2c1N
Standard InChI: InChI=1S/C13H10Cl2N4O/c1-19-11(16)7-5-6(13(20)17-12(7)18-19)10-8(14)3-2-4-9(10)15/h2-5H,16H2,1H3,(H,17,18,20)
Standard InChI Key: SCPLWEIGLJKPMN-UHFFFAOYSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 309.16 | Molecular Weight (Monoisotopic): 308.0232 | AlogP: 2.82 | #Rotatable Bonds: 1 |
Polar Surface Area: 76.70 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.06 | CX Basic pKa: 0.58 | CX LogP: 2.76 | CX LogD: 2.76 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.73 | Np Likeness Score: -0.89 |
References
1. Bou-Petit E, Hümmer S, Alarcon H, Slobodnyuk K, Cano-Galietero M, Fuentes P, Guijarro PJ, Muñoz MJ, Suarez-Cabrera L, Santamaria A, Estrada-Tejedor R, Borrell JI, Ramón Y Cajal S.. (2022) Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor., 65 (8.0): [PMID:35417652] [10.1021/acs.jmedchem.1c01941] |